Iriska Pharmaceuticals Private Limited
About Iriska Pharmaceuticals Private Limited
Data last updated:
Iriska Pharmaceuticals Private Limited is a private limited company based in Hapur, Uttar Pradesh, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 16 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U74999UP2018PTC103206. Its GSTIN is 09AAECI8432P1ZX (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rahul Yadav and Priyanka Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 4 First Floor City Plaza Gandhi Bazar Pilkhuwa, Hapur, Uttar Pradesh, India – 245304.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.03 Cr, a growth of 52% compared to the previous year. For the same year it recorded a net profit of ₹1.18 Lakh (net margin 0.4%) and EBITDA of ₹2.4 Lakh (EBITDA margin 0.8%). Revenue has grown at a compounded annual rate (CAGR) of 58% over three years and 50% over five years.
Company details
Contact details
Iriska Pharmaceuticals Private Limited's registered office is in Hapur, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressShop No. 4 First Floor City Plaza Gandhi Bazar Pilkhuwa, Hapur, Uttar Pradesh, India – 245304
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Iriska Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Iriska Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Iriska Pharmaceuticals Private Limited, buy the company report.
Financials of Iriska Pharmaceuticals Private Limited
FY 2025 filings availableIriska Pharmaceuticals Private Limited reported revenue of ₹3.03 Cr (up 52% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 50% over five years, including 52% growth in the latest year. EBITDA rose 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.4 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.18 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.8% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Iriska Pharmaceuticals Private Limited, buy the company report.
Board of directors of Iriska Pharmaceuticals Private Limited
Iriska Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rahul Yadav | Director | 16 Apr 2018 | 8 Years 6 Months | Current |
| Priyanka Sharma | Director | 16 Apr 2018 | 8 Years 6 Months | Current |
Legal cases
No court or tribunal cases involving Iriska Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Iriska Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Iriska Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECI8432P1ZX | Uttar Pradesh | Active | 26 Apr 2018 |
To see the full GST registrations and return filing status of Iriska Pharmaceuticals Private Limited, buy the company report.
Recent activity
Iriska Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Priyanka Sharma was appointed as Director on 16 Apr 2018.
Frequently asked questions
Iriska Pharmaceuticals is an active private limited company based in Hapur, Uttar Pradesh, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 16 April 2018 (8+ years old) and is registered under CIN U74999UP2018PTC103206.
Iriska Pharmaceuticals has 2 current directors:
- Rahul Yadav - Director
- Priyanka Sharma - Director
The latest financial statements of Iriska Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Iriska Pharmaceuticals is 09AAECI8432P1ZX, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Iriska Pharmaceuticals is U74999UP2018PTC103206. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Iriska Pharmaceuticals was incorporated on 16 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Priyanka Sharma was appointed as Director on 16 Apr 2018. Rahul Yadav was appointed as Director on 16 Apr 2018.
The registered office of Iriska Pharmaceuticals is at Shop No. 4 First Floor City Plaza Gandhi Bazar Pilkhuwa, Hapur, Uttar Pradesh, India – 245304.
Iriska Pharmaceuticals operates in the healthcare industry, in the preventive health services segment.
Iriska Pharmaceuticals can be reached at its registered office: Shop No. 4 First Floor City Plaza Gandhi Bazar Pilkhuwa, Hapur, Uttar Pradesh, India – 245304.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
